Literature DB >> 11735131

Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.

E Malle1, G Wäg, J Thiery, W Sattler, H J Gröne.   

Abstract

Myeloperoxidase (MPO), a heme enzyme secreted by activated phagocytes, generates an array of oxidants proposed to play critical roles in host defense, tissues damage, and foam cell formation. Although neutrophils are the major source for MPO, the enzyme could be identified abundantly in circulating monocytes and monocytes/macrophages in rabbit lesions. MPO is the only enzyme known to generate hypochlorous acid (HOCl) and HOCl-modified lipoproteins have pronounced atherogenic and/or proinflammatory features in vivo and in vitro. Using specific monoclonal antibodies, HOCl-modified (lipo)proteins were detected in atherosclerotic plaques of heterozygous Watanabe heritable hyperlipidemic rabbits and to a lesser extent in a specific strain of New Zealand White rabbits with a high atherosclerotic response to hypercholesterolemia. Colocalization of immunoreactive MPO and HOCl-modified-epitopes in serial sections of rabbit lesions provides convincing evidence for MPO-H2O2-chloride system-mediated oxidation of (lipo)proteins under in vivo conditions. We propose that monocyte-derived MPO could connect chronic inflammatory conditions with arterial lipid/lipoprotein deposition during diet-induced atherogenesis in rabbits. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735131     DOI: 10.1006/bbrc.2001.6074

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Risk of gestational diabetes mellitus in relation to maternal egg and cholesterol intake.

Authors:  Chunfang Qiu; Ihunnaya O Frederick; Cuilin Zhang; Tanya K Sorensen; Daniel A Enquobahrie; Michelle A Williams
Journal:  Am J Epidemiol       Date:  2011-02-15       Impact factor: 4.897

Review 2.  Halogenation Activity of Mammalian Heme Peroxidases.

Authors:  Jürgen Arnhold; Ernst Malle
Journal:  Antioxidants (Basel)       Date:  2022-04-30

3.  Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.

Authors:  Gunther Marsche; Paul G Furtmüller; Christian Obinger; Wolfgang Sattler; Ernst Malle
Journal:  Cardiovasc Res       Date:  2008-02-23       Impact factor: 10.787

Review 4.  High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Authors:  Edward A Fisher; Jonathan E Feig; Bernd Hewing; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12       Impact factor: 8.311

Review 5.  Myeloperoxidase, modified lipoproteins, and atherogenesis.

Authors:  Stephen J Nicholls; Stanley L Hazen
Journal:  J Lipid Res       Date:  2008-12-16       Impact factor: 5.922

Review 6.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

7.  Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway.

Authors:  Gunther Marsche; Michaela Semlitsch; Astrid Hammer; Sasa Frank; Bernd Weigle; Nina Demling; Kurt Schmidt; Werner Windischhofer; Georg Waeg; Wolfgang Sattler; Ernst Malle
Journal:  FASEB J       Date:  2007-01-11       Impact factor: 5.191

8.  Hypochlorite-modified high-density lipoprotein promotes induction of HO-1 in endothelial cells via activation of p42/44 MAPK and zinc finger transcription factor Egr-1.

Authors:  Christine Rossmann; Anamaria Rauh; Astrid Hammer; Werner Windischhofer; Sandra Zirkl; Wolfgang Sattler; Ernst Malle
Journal:  Arch Biochem Biophys       Date:  2011-02-24       Impact factor: 4.013

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.